Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab with Docetaxel and Capecitabine in HER2-positive advanced gastric cancer
NCT02004769Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2013
- Primary completion
- Jun 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Sun Yat-sen University. Started Nov 2013; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT02004769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02004769.